ReviewTherapeutic advances in endocrinology and metabolism2022

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?

Aditi Ujjawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.